Related Experiment Videos
[Anticoagulation: assessment of benefits and risks]
1Abteilung für Kardiologie, Universität Rostock.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
|September 1, 1993
Summary
Anticoagulation significantly reduces thromboembolism in atrial fibrillation patients. Careful risk-benefit assessment is crucial for individual treatment decisions.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Context:
- Atrial fibrillation is a common arrhythmia associated with a high risk of thromboembolic events.
- Previous research has established the efficacy of anticoagulation in managing this risk.
Purpose:
- To review the evidence from placebo-controlled studies on anticoagulation in atrial fibrillation.
- To discuss the principles for weighing the risks and benefits of anticoagulation in clinical practice.
Summary:
- Multiple prospective, placebo-controlled studies demonstrate that anticoagulation significantly lowers the incidence of thromboembolism in patients with atrial fibrillation.
- The effectiveness of anticoagulation spans nearly all types of atrial fibrillation.
- These findings necessitate a careful evaluation of individual patient risks and benefits.
Impact:
- Provides a framework for clinicians to make informed decisions regarding anticoagulation therapy in atrial fibrillation.
- Highlights the importance of personalized medicine in managing cardiovascular complications.
- Contributes to optimizing patient outcomes by balancing therapeutic benefits against bleeding risks.